New York, Oct. 21, 2022 (GLOBE NEWSWIRE) -- The global hypercholesterolemia treatment market is anticipated to grow from a value of US$ 27 Bn in 2022 to US$ 34 Bn by the end of 2032, progressing at a CAGR of 2.3% through 2032.
Hypercholesterolemia is a genetic disorder characterized by very high levels of cholesterol in the blood. Hypercholesterolemia, also termed dyslipidemia, is a form of hyperlipidemia and hyperlipoproteinemia in the body. The presence of low-density Lipoprotein Cholesterol (LDL-C) or bad cholesterol in the blood, may lead to cardiovascular diseases.
Hypercholesterolemia is caused due to a combination of genetic and environmental factors. Environmental factors include excessive diet intake and obesity. In the case of genetic factors, the number of copies of the gene determines the severity of the disease.
People with the homozygous form (two copies of the gene) generally suffer from severe cardiovascular diseases during childhood, while those with the heterozygous form (with a single copy of the gene) suffer from heart diseases in their 30s or 40s.
Request for sample copy of report: https://www.persistencemarketresearch.com/samples/4485
Rising awareness related to many cardiovascular diseases along with the availability of their respective treatment solutions is also likely to fuel growth avenues in the global hypercholesterolemia treatment market.
Key Takeaways from Market Study
- One of the noticeable factors that are creating novel growth opportunities in the hypercholesterolemia treatment market is a rapid increase in the healthcare issues about disturbed cholesterol levels in human blood.
- Technological advancements that are taking place in the field of hypercholesterolemia treatment are also driving growth avenues in the regional market.
- The global hypercholesterolemia treatment market is anticipated to evolve at a CAGR of 2.3% through 2032.
Know the methodology of report: https://www.persistencemarketresearch.com/methodology/4485
Growing demographic economies in developing countries such as India and China are expected to offer good opportunities for the global hypercholesterolemia treatment market. Innovation of some new products with better efficiency is also expected to create good opportunities for the market.
Market Landscape
Rising number of mergers and acquisitions, new product launches, and increasing number of collaborations and partnerships are some of the latest trends that have been observed in the global hypercholesterolemia treatment market. Side effects associated with the intake of statins are a challenge for the market.
Some of the major companies operating in the hypercholesterolemia treatment market include AbbVie, Inc., Astrazeneca Plc, Merck & Co., Inc., and Pfizer, Inc. Other companies having a significant presence in the global hypercholesterolemia treatment market include Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Regeneron Pharmaceuticals Inc., Bristol-Myers Squibb Company, Alnylam Pharmaceuticals Inc., Cerenis Therapeutics Holding SA, REGENX BioSciences, LLC, and Tekmira Pharmaceuticals Corporation.
Get full access of report: https://www.persistencemarketresearch.com/checkout/4485
Want to Know More?
Persistence Market Research, a research and consulting firm, has published a revised market research report on the electric cargo bike market that contains a global industry analysis of 2017–2021 and an opportunity assessment for 2022–2032. The report provides in-depth analysis of the market through different segments, namely, product type, battery type, end use, and region.
Other Trending Reports:
- Oncology Drugs Market
- Dermacosmetics Market
- Molecular Diagnostics in Infectious Disease Testing Market
- Metabolic Testing Market
- Dental Imaging Market
- Medical Implants Market
- Human Augmentation Market
- Hypercholesterolemia Treatment Market
- Bladder Cancer Treatment Drugs Market
- Acquired Orphan Blood Disease Market
About Persistence Market Research:
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges.
Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies’/clients’ shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part.
Contact
Rajendra Singh
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
+1-646-568-7751
United States
USA - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com
